News

Our Baby Care team recently hosted an engaging and insightful Round Table discussion with leading pediatricians, focusing on the prevention of recurrent respiratory tract infections (RTIs) in children. The session highlighted the role of Lyophilized Bacterial Lysates as a promising solution for boosting immunity and reducing the frequency of RTIs in young patients. The event

ZAS Corporation Ltd. is proud to announce the signing of a Memorandum of Understanding (MOU) with The Ibn Sina Trust, marking the beginning of a strategic corporate partnership. This collaboration aims to prioritize the well-being of ZAS employees by providing access to comprehensive health check-ups and premium medical facilities. The agreement underscores ZAS Corporation’s unwavering

ZAS Corporation Headquarters team wrapped up 2024 with an unforgettable recreation tour to the picturesque beaches of Kuakata. Surrounded by serene sea views, the team embraced moments of relaxation, rejuvenation, and connection. The retreat was packed with exciting activities, including games, strategic discussions, and team-building exercises, fostering collaboration and unity. This year-end getaway not only

ZAS Corporation Ltd. is delighted to announce the signing of a Memorandum of Understanding (MOU) with LABAID Diagnostics and LABAID Cancer Hospital & Super Speciality Centre. This strategic partnership aims to provide employees with access to comprehensive health check-ups and state-of-the-art medical facilities. By joining forces with LABAID, ZAS Corporation reinforces its dedication to fostering

ZAS Corporation proudly launched Uro-Vaxom, an advanced immunotherapeutic solution by OM Pharma, Switzerland, for preventing recurrent urinary tract infections (UTIs). The launch event brought together leading healthcare professionals to discuss Uro-Vaxom’s role in boosting immune defense and reducing UTI recurrence, marking a significant milestone in UTI care. This innovative product reflects ZAS Corporation’s commitment to

In collaboration with the Nephrology Department at the National Institute of Kidney Diseases & Urology (NIKDU), ZAS Corporation Ltd. hosted a Virtual CME on “Induction Therapy in Immunologically High-risk vs Low-risk Kidney Transplant Recipients.” Prof. Hüseyin Koçak from Akdeniz University Hospital, Antalya, Türkiye, joined virtually, providing valuable insights into personalized approaches in kidney transplant care.